Repligen (RGEN) Liabilities and Shareholders Equity (2011 - 2026)

Repligen (RGEN) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $2.9 billion in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.9 billion, up 2.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.7 billion (up 2.88% YoY), and the FY2025 annual result was $2.9 billion, up 4.24% from the prior year.
• Liabilities and Shareholders Equity retreated to $2.9 billion in Q1 2026 per RGEN's latest filing, from $2.9 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.9 billion in Q4 2025 and troughed at $2.4 billion in Q1 2022.
• A 5-year average of $2.7 billion and a median of $2.8 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity climbed 23.69% in 2022, then slipped 0.05% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.5 billion in 2022, then gained by 11.83% to $2.8 billion in 2023, then retreated by 0.05% to $2.8 billion in 2024, then gained by 4.24% to $2.9 billion in 2025, then decreased by 0.64% to $2.9 billion in 2026.
• Business Quant data shows RGEN's Liabilities and Shareholders Equity at $2.9 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.